IDVSmall business
IDC (single-award IDV) 75A50119D00010CYTOVALE INC
Overview
Award facts
- Orders under this IDV
- No orders recorded under this IDV.
- Period of performance
- From Dec 1, 2018
- Modifications
- 2
- Latest action Jul 1, 2020
- Contract type
- IDC (single-award IDV)
- PIID 75A50119D00010
Description of requirement
IGF::OT::IGF CYTOVALE SEPTISCAN BETA CLINICAL STUDY
Dates and value
- Award date
- Signed on Nov 14, 2018
- Ordering period ends
- Jul 1, 2020
- Ceiling
- Ceiling (single-award vehicle): $749,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 1, 2020. View on USAspending · Recipient on SAM.gov
Recipient
NameCYTOVALE INC
LocationSAN FRANCISCO, CA
UEITG7HM4HD8594
CAGE code6PS42
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyCYTOVALE INC
Business types and certifications
Minority-ownedSelf-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- 075-0140Federal accounts (agency financial reports)
Classification and competition
Classification
- Product or service (PSC)
- AN13R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- BAA18100SOL00018(as reported)
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Cytovale septiscan beta clinical study
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- Yes - service where PBA is used.Y
Transaction history
Modification history
- Base award
- Nov 14, 2018Base obligation at award: $749,000
- Latest action
- Jul 1, 2020 — CloseoutModification P00002; administrative: no change in scope or value
- Latest substantive action
- Aug 22, 2019 — Change orderModification P00001
- Actions by type
- Base award1
- Change order1
- Closeout1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- Environmentally preferableF
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
Structure
- Award or IDV
- IDV
- IDV type
- IDCB
- Indefinite-delivery contract type
- Indefinite delivery / requirementsA
- Multiple or single award
- Single awardS
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 3
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-2019/2020-0140-000
- Object classes
- 25.1: Advisory and assistance services